SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-015096
Filing Date
2021-06-17
Accepted
2021-06-17 17:11:19
Documents
14
Period of Report
2021-06-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20210617_8k.htm   iXBRL 8-K 52518
2 EXHIBIT 10.1 ex_258026.htm EX-10.1 221488
  Complete submission text file 0001437749-21-015096.txt   458184

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acrx-20210617.xsd EX-101.SCH 3700
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20210617_def.xml EX-101.DEF 11975
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20210617_lab.xml EX-101.LAB 16020
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20210617_pre.xml EX-101.PRE 12184
7 EXTRACTED XBRL INSTANCE DOCUMENT acrx20210617_8k_htm.xml XML 2665
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 211025700
SIC: 2834 Pharmaceutical Preparations